Published in Clin Exp Immunol on April 01, 1982
Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest (2005) 1.95
Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J Immunol (2005) 1.43
Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens? Clin Exp Immunol (1983) 0.81
Distribution of nominal and latent IgG (Gm) allotypes in plaques of multiple sclerosis brain. Clin Exp Immunol (1983) 0.81
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (1962) 64.93
Quantitation of staphylococcal protein A: Determination of equilibrium constant and number of protein A residues on bacteria. J Immunol (1970) 2.19
Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1973) 2.10
Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest (1978) 1.99
Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis. Neurology (1978) 1.44
Binding of normal human IgG to myelin sheaths, glia and neurons. Immunology (1975) 1.39
On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system. J Neurol Sci (1970) 1.35
Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature (1980) 1.28
Multiple sclerosis: a quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system. Neuropathol Appl Neurobiol (1980) 1.26
Fluorescent protein tracing in multiple sclerosis brain tissue. Arch Neurol (1969) 1.14
Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. Am J Pathol (1975) 1.04
Biochemical findings in multiple sclerosis IV. Isoelectric focusing of the CSF gamma globulins in multiple sclerosis (262 cases) and other neurological diseases (272 cases). J Neurol (1977) 1.03
Demonstration of electrophoretically restricted virus-specific antibodies in serum and cerebrospinal fluid by imprint electroimmunofixation. Scand J Immunol (1978) 1.02
Immunoglobulin G distribution in multiple sclerosis brain. An immunofluorescence study. J Neurol Sci (1975) 1.00
[125I]protein A: a tracer for general use in immunoassay. J Immunol Methods (1978) 0.97
Isoelectric focusing of CSF proteins in neurological diseases. J Neurol Sci (1974) 0.94
Oligodendrocyte staining by multiple sclerosis serum is nonspecific. Ann Neurol (1979) 0.92
Studies of the IgM and IgA contamination obtained by eluting IgG from protein A-Sepharose column with pH steps. J Immunol Methods (1980) 0.85
Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy. J Neurol Sci (1978) 0.85
Immunoglobulin G from subacute sclerosing panencephalitis brain as an immunological reagent. Infect Immun (1979) 0.78
Crossed immunoelectrofocusing of cerebrospinal fluid immunoglobulins. J Neurol (1977) 0.78
Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med (1990) 9.62
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain (2000) 2.84
Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med (1995) 2.28
Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain (1998) 2.16
31P nuclear magnetic resonance studies of bioenergetics and glycolysis in anaerobic Escherichia coli cells. Proc Natl Acad Sci U S A (1978) 1.92
Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. Proc Natl Acad Sci U S A (1992) 1.88
Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol (1998) 1.86
High-resolution 13C nuclear magnetic resonance studies of glucose metabolism in Escherichia coli. Proc Natl Acad Sci U S A (1978) 1.79
Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol (2000) 1.63
Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol (1991) 1.63
Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol (1999) 1.61
High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cord. J Neurol (2003) 1.59
Neuropathy target esterase and a homologous Drosophila neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man. Biochem J (1998) 1.52
Microglia are the major cell type expressing MHC class II in human white matter. J Neurol Sci (1987) 1.50
The lipid composition of rat brain myelin and subcellular fractions during development. Biochem J (1968) 1.39
Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine (1993) 1.37
The chemical composition of vertebrate myelin and microsomes. J Neurochem (1965) 1.37
P nuclear magnetic resonance studies of isolated rat liver cells. Nature (1978) 1.34
Neuroinvasion by human respiratory coronaviruses. J Virol (2000) 1.33
T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions. J Exp Med (1992) 1.30
Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain (1991) 1.26
Quantitative thin layer chromatography of lipids. J Chromatogr (1967) 1.24
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. J Neuroimmunol (2007) 1.23
Astrocyte characterization in the multiple sclerosis glial scar. Neuropathol Appl Neurobiol (2003) 1.22
The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection. AIDS (1999) 1.22
Subunit composition of Kv1 channels in human CNS. J Neurochem (1999) 1.22
Generation and characterization of a PhoP homologue mutant of Neisseria meningitidis. Mol Microbiol (2001) 1.21
The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J Neuropathol Exp Neurol (1996) 1.18
Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol (2000) 1.17
On the measurement of pH in Escherichia coli by 31P nuclear magnetic resonance. Biochim Biophys Acta (1978) 1.17
13C NMR study of gluconeogenesis from labeled alanine in hepatocytes from euthyroid and hyperthyroid rats. Proc Natl Acad Sci U S A (1981) 1.15
Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J Neurol Sci (1986) 1.15
Fluorescence measurement of calcium transients in perfused rabbit heart using rhod 2. Am J Physiol (1998) 1.14
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Brain (2002) 1.13
Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. J Neuroimmunol (2000) 1.13
Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage. Brain (2001) 1.10
Characterisation of microglia isolated from adult human and rat brain. J Neuroimmunol (1988) 1.10
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies. Ann Oncol (2008) 1.09
Neuropathy target esterase (NTE) and organophosphorus-induced delayed polyneuropathy (OPIDP): recent advances. Toxicol Lett (1995) 1.09
The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat. Clin Exp Immunol (1982) 1.08
Apoptotic pathways mobilized in microglia and neurones as a consequence of chromogranin A-induced microglial activation. J Neurochem (1999) 1.06
Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis. Proc Natl Acad Sci U S A (2000) 1.05
Cloning and expression of the murine sws/NTE gene. Mech Dev (2000) 1.05
Competition between foreign and self proteins in antigen presentation. Ovalbumin can inhibit activation of myelin basic protein-specific T cells. J Immunol (1990) 1.04
Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types. Biochem J (1996) 1.04
Dendritic spine loss and neurodegeneration is rescued by Rab11 in models of Huntington's disease. Cell Death Differ (2010) 1.04
Phosphorus-31 nuclear magnetic resonance studies of bioenergetics in wild-type and adenosinetriphosphatase(1-) Escherichia coli cells. Biochemistry (1982) 1.03
Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790. Inflamm Res (1995) 1.02
Lipocortins (annexins) 1, 2, 4 and 5 are increased in the central nervous system in multiple sclerosis. J Neuroimmunol (1992) 1.02
New mother groups as a social network intervention: consumer and maternal and child health nurse perspectives. Aust J Adv Nurs (2002) 1.02
Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol Appl Neurobiol (1993) 1.01
Naturally occurring insertional inactivation of the porA gene of Neisseria meningitidis by integration of IS1301. Mol Microbiol (1998) 1.01
Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling. Neuropathol Appl Neurobiol (1999) 1.01
Rapid analysis of immunoglobulin isoelectric focusing patterns with cellulose nitrate sheets and immunoperoxidase staining. J Immunol Methods (1982) 1.01
Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. Neuroscience (2005) 0.99
A novel metalloproteinase associated with brain myelin membranes. Isolation and characterization. J Biol Chem (1989) 0.98
Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol Appl Neurobiol (1994) 0.98
Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease. J Neurochem (2002) 0.98
Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis. J Neurol Sci (1982) 0.97
Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions. J Neuropathol Exp Neurol (1998) 0.97
Peroxiredoxin V in multiple sclerosis lesions: predominant expression by astrocytes. Mult Scler (2007) 0.96
Membrane association of and critical residues in the catalytic domain of human neuropathy target esterase. J Biol Chem (2000) 0.94
Macrophages in CNS remyelination: friend or foe? Neurochem Res (1998) 0.93
Myelinogenesis in the rat brain. Nature (1966) 0.93
Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat. Am J Pathol (1997) 0.93
Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol Appl Neurobiol (1996) 0.93
Distribution of glial fibrillary acidic protein in gliosed human white matter. J Neurochem (1986) 0.91
High resolution proton NMR spectroscopy of multiple sclerosis lesions. J Neurochem (1995) 0.91
Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis. Eur Neurol (1992) 0.91
High-resolution 31P nuclear magnetic resonance study of rat liver mitochondria. Proc Natl Acad Sci U S A (1978) 0.91
Fc receptor density, MHC antigen expression and superoxide production are increased in interferon-gamma-treated microglia isolated from adult rat brain. Immunology (1989) 0.91
Use of rubella virus E1 fusion proteins for detection of rubella virus antibodies. J Clin Microbiol (1995) 0.90
Insulin-like growth factors and binding proteins in multiple sclerosis plaques. Neuropathol Appl Neurobiol (1999) 0.89
The nature of inflammatory components during demyelination in multiple sclerosis. J Neuroimmunol (1988) 0.89
Monoclonal antibody 14E identifies the oligodendrocyte cell body in normal adult human and rat white matter. J Neuroimmunol (1988) 0.88
Amyloid precursor protein (APP) expression in multiple sclerosis lesions. Glia (1995) 0.88
Membrane-associated metalloproteinase recognized by characteristic cleavage of myelin basic protein: assay and isolation. Methods Enzymol (1995) 0.88
Analysis by transfer electrophoresis of reactivity of IgG with brain proteins in multiple sclerosis. J Neurochem (1982) 0.87